In vitro and in vivo consideration of novel environmentally responsive ophthalmic drug delivery system

Pharmaceutical Development and Technology

Volumn 18, Issue 4, 2013, Pages 950-956

  Deshmukh, Prashant K ^a   Gattani, Surendra G ^a  

^a RCPIPER   (India)

Author keywords

in situ gel; Ofloxacin; Polyacrylic acid; Xanthan gum

Indexed keywords

CARBOMER; CHLORIDE; OFLOXACIN; POLYACRYLIC ACID; XANTHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EXPERIMENTAL RABBIT; EYE IRRITATION; FEMALE; FLOW KINETICS; GELATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PH; PHASE TRANSITION; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TIME PERCEPTION;

ACRYLATES; ADMINISTRATION, OPHTHALMIC; ANIMALS; ANTI-BACTERIAL AGENTS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; FEMALE; GELS; HYDROGEN-ION CONCENTRATION; OFLOXACIN; PHASE TRANSITION; POLYSACCHARIDES, BACTERIAL; RABBITS; RHEOLOGY; TIME FACTORS;

EID: 84877844408     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2011.644297     Document Type: Article

References (27)

1. Olejnik O. Conventional systems in ophthalmic drug delivery. In: Mitra AK (ed). Ophthalmic Drug Delivery Systems. New York: Marcel Dekker, Inc; 1993. pp 177-198.
2. Yusuf A, Kari L. Industrial perspective in ocular drug delivery. Adv Drug Del Rev 2006;58:1258-1268.
3. Chrystele LB, Liliane A, Hosein Z, Pierre AS, Thomas N, Roger L. Ophthalmic drug delivery systems recent advances. Prog Ret Eye Res 1998;17:33-58.
4. Robinson JR, Mlynek GM. Bioadhesive and phase-change polymers for ocular drug delivery. Adv Drug Del Rev 1995;16:45-50.
5. Cohen S, Lobel E, Trevgoda A, Peled Y. A novel in-situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye. J Control Release 1997;44:201-208.
6. Gurny R. Preliminary study of prolonged acting drug delivery system for the treatment of glaucoma. Pharm Acta Helv 1981;56:130-132.
7. Gurny R, Boye T, Ibrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery. J Control Release 1985;2:353-361.
8. Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release 2001;73:205-211.
9. Miller SC, Donovan MD. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. Int J Pharm 1982;12:147-152.
10. Desai SD, Blanchard J. In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine. J Pharm Sci 1998;87:226-230.
11. Vadnere M, Amidon G, Lindenbaum S, Haslam JL. Thermodynamic studies on the gel-sol transition of some pluronic polyols. Int J Pharm 1984;22:207-218.
12. Spancake CW, Mitra AK, Kildsig DO. Kinetics of aspirin hydrolysis in aqueous solutions and gels of poloxamines (Tetronic 1508) influence of microenvironment. Int J Pharm 1991;75:231-239.
13. Rozier A, Manuel C, Groove J, Plazonnet B: Gelrite. A novel, ionactivated, in situ gelling polymer for ophthalmic vehicles: Effect on bioavailability of timolol. Int J Pharm 1989;57:163-168.
14. Sanzgiri YD, Maschi S, Crescenzi V, Callegaro L, Topp EM, Stella VJ. Gellan-based systems for ophthalmic sustained delivery of methylprednisolone. J Control Release 1993;26:195-201.
15. Zhidong L, Jiawei L, Shufang N, Hui L, Pingtian D, Weisan P. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm 2006;315:12-17.
16. Deshmukh PK, Gattani SG. Design and characterization of a novel environmentally responsive ophthalmic drug delivery system. Eur J Par Pharm Sci 2011;16:87-91.
17. Hongyi Q, Wenwen C, Chunyan H. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm 2007;337:178-187.
18. Deshmukh PK, Fursule RA. Study of a novel environmentally responsive ophthalmic drug delivery system. Int J Pharm Bio Sci 2010;1:1-13.
19. Davies NM, Farr SJ, Hadgraft J, Kellaway IW. Evaluation of mucoadhesive polymers in ocular drug delivery. I. Viscous solutions. Pharm Res 1991;8:1039-1043.
20. Patton TF, Robinson Jr. Ocular evaluation of polyvinyl alcohol vehicle in rabbits. J Pharm Sci 1975;64:1312-1316.
21. Kumar S, Haglund BO, Himmelstein KJ. In situ-forming gels for ophthalmic drug delivery. J Ocul Pharmacol 1994;10:47-56.
22. Kumar S, Himmelstein KJ. Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose. J Pharm Sci 1995;84:344-348.
23. Lin HR, Sung KC. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Control Release 2000;69:379-388.
24. Nanjawade BK, Manvi FV, Manjappa AS. In situ-forming hydrogels for sustained ophthalmic drug delivery. J Control Release 2007;122:119-134.
25. Ravichandran M, Xiaoling L, Bhaskara RJ. Semisolid dosages: ointments, creams, and gels. In: Shayne CG, (eds). Pharmaceutical Manufacturing Handbook Production and Processes. New Jersey: John Wiley & Sons, Inc.; 2008. pp 267-312.
26. Mikac U, Sepe A, Kristl J, Baumgartner S. A new approach combining different MRI methods to provide detailed view on swelling dynamics of xanthan tablets influencing drug release at different pH and ionic strength. J Control Release 2010;145:247-256.
27. Wen-Di M, Hui X, Chao W. Pluronic F127-g-poly (acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system. Int J Pharm 2008;350:247-256.